Discussion about this post

User's avatar
Rainbow Roxy's avatar

Hey, great read as always. Your insights into Meta's crisis and Anthropic's bold bet truely highlight the exciting, yet volatile, nature of tech right now. Thanks for keeping us so well-informed!

Expand full comment
Neural Foundry's avatar

The flight to quality thesis you outline here is spot on, especially with JNJ as one of the fortress plays. What's often overlooked is how their pharmaceutical pipeline has been strenghtening, particularly in oncology and immunology. The consumer spinoff reduces some complexity but doesn't change the core thesis that in uncertain markets, people still get sick and need treatment. One thing I'd add is their international exposure actually gives them som diversification that pure domestic plays don't have, even if currency headwinds can be a drag short-term.

Expand full comment

No posts

Ready for more?